Jim Cramer Recommends Not Selling Vertiv, Says Buy This Social Media Stock 'Hand Over Fist'
Portfolio Pulse from Avi Kapoor
Jim Cramer provided stock recommendations on CNBC's 'Mad Money Lightning Round.' He advised holding Salesforce (CRM), taking profits on ADMA Biologics (ADMA) and Ouster (OUST), holding Vertiv Holdings (VRT) and Suncor Energy (SU), and buying Pinterest (PINS) aggressively. Recent analyst ratings and upcoming earnings reports were also highlighted.
July 23, 2024 | 1:16 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Jim Cramer recommends holding Cava Group and buying more if the stock drops. Morgan Stanley recently raised its price target.
Cramer's recommendation to hold and buy more on dips, along with the raised price target, suggests potential for growth.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Jim Cramer recommends holding Salesforce, citing it as a huge winner despite some traction issues. The company recently cut 300 roles to streamline operations.
Cramer's positive outlook and the company's cost-cutting measures suggest potential for continued growth.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Jim Cramer recommends buying Pinterest aggressively. The company will release its Q2 financial results on July 30.
Cramer's strong buy recommendation and the upcoming earnings report suggest potential for short-term price appreciation.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Jim Cramer recommends holding Suncor Energy, stating that investors are in good shape with it. Wolfe Research recently reinstated it with an Outperform rating.
Cramer's positive outlook and the recent analyst rating suggest potential for continued growth.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Jim Cramer recommends holding Vertiv Holdings and not selling it. The company will report its Q2 results on July 24.
Cramer's recommendation to hold suggests confidence in the company's upcoming earnings report.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Jim Cramer suggests taking some profits on ADMA Biologics after its strong Q1 results and positive FY24 and FY25 revenue guidance.
Cramer's recommendation to take profits indicates a potential short-term price decline despite strong financial performance.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Jim Cramer recommends taking some profits on Ouster, suggesting the stock has gotten ahead of itself amid a small-cap rally.
Cramer's advice to take profits suggests a potential short-term price decline as the stock may be overvalued.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70